OmniAb (OABI) EBITDA Margin (QoQ) (2022 - 2026)
OmniAb (OABI) EBITDA Margin (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | OmniAb | 261.62 Mn | 212.55 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,396.00 |
| Dec 31, 2025 | 62,195.00 |
| Sep 30, 2025 | -39,399.00 |
| Jun 30, 2025 | 3,744.00 |
| Mar 31, 2025 | -30,665.00 |
| Dec 31, 2024 | 32,675.00 |
| Sep 30, 2024 | -25,958.00 |
| Jun 30, 2024 | 37,920.00 |
| Mar 31, 2024 | -15,357.00 |
| Dec 31, 2023 | -6,886.00 |
| Sep 30, 2023 | -9,097.00 |
| Jun 30, 2023 | -22,998.00 |
| Mar 31, 2023 | -7,557.00 |
| Dec 31, 2022 | 24,136.00 |
| Sep 30, 2022 | -4,121.00 |
| Jun 30, 2022 | -8,910.00 |